What causes ADHD? The current scientific answer
Attention-deficit/hyperactivity disorder (ADHD) develops through interacting genetic, neurodevelopmental, prenatal, perinatal, and environmental influences. Its origins usually begin early in development, while its clinical expression unfolds as a child encounters changing demands for attention, behavioral regulation, organization, and self-direction. Research strongly supports a substantial inherited component. It also identifies developmental conditions and exposures associated with later ADHD, but their causal status varies considerably. A risk factor raises the probability of an outcome across a population; it does not establish the cause of any one person's diagnosis.
For most individuals, scientists cannot reconstruct a single decisive causal event. An ADHD diagnosis describes a clinically significant developmental pattern of inattention and/or hyperactivity-impulsivity, with functional impairment across relevant settings, rather than a laboratory-confirmed molecular cause. ADHD is a recognized neurodevelopmental disorder, and assessment requires a developmental and clinical history, information about functioning, and consideration of alternative and co-occurring conditions. The National Institute of Mental Health, CDC, and NICE guidance NG87 make these distinctions explicit.
An etiological explanation must connect population-level vulnerability, the developing nervous system, timing of exposures, and circumstances that alter symptom visibility. These are related questions, but each requires separate evidence. A genetic correlation is evidence of shared inherited liability; an association with pregnancy complications may reflect prenatal mechanisms or shared family characteristics; a difficult classroom can make impairment more pronounced without causing the underlying neurodevelopmental condition. The World Federation of ADHD consensus statement emphasizes that many environmental correlates remain incompletely resolved as causes.
What does it mean to investigate the cause of ADHD?
Etiology, risk, mechanism, and manifestation
Etiology concerns how a disorder originates. Risk refers to the statistical probability of its occurrence. A mechanism is a biological, developmental, psychological, or social process that might connect an exposure or predisposition to an outcome. Manifestation describes the symptoms and impairments observed at a particular developmental stage. These levels cannot be substituted for one another. A child who becomes more distractible during sleep deprivation may have worsening attention without newly developing ADHD. A genetically predisposed child may show ADHD in supportive or stressful circumstances, with different degrees of impairment.
Researchers frequently study ADHD as a categorical clinical diagnosis, a continuous symptom dimension, or a pattern of behavioral ratings. Those outcomes overlap but are not identical. Research on teacher-rated hyperactivity may not transfer directly to clinician-diagnosed ADHD. Likewise, an experimental deficit in working memory, response inhibition, or sustained attention is neither necessary nor sufficient for diagnosis. The relevant clinical question integrates developmental persistence, contextual breadth, impairment, and differential assessment, as specified by NICE.
Population associations and individual explanations
When an exposure is more common among children later diagnosed with ADHD, several explanations remain possible. The exposure could affect neurodevelopment; a parental characteristic could influence both exposure and inherited vulnerability; socioeconomic conditions could influence measurement and access to diagnosis; or a third biological process might cause both the exposure marker and the outcome. Even a statistically precise association may leave these mechanisms unresolved. Therefore, etiological conclusions require convergent evidence rather than interpretation of one relative risk or odds ratio.
The probability of ADHD differs among family groups, pregnancy histories, birth cohorts, and environments. Such differences help prioritize research and prevention of harmful exposures. They do not support retrospective certainty about an individual's pregnancy, parenting, family relationship, or daily behavior. Effective care can proceed on a valid clinical diagnosis even when its precise origins remain unknown.
Genetic susceptibility: the strongest established contributor
Family, twin, and adoption evidence
ADHD frequently runs in families. Twin and family studies consistently identify substantial genetic contributions to variation in ADHD liability. A major review by Faraone and Larsson reports a heritability estimate around 74 percent in the studies assessed. This is a population-specific estimate of the contribution of genetic differences to variation in liability under the sampled conditions. It does not mean that 74 percent of an individual person's ADHD is genetic, that environmental influences are negligible, or that a diagnosis is predetermined.
Heritability changes with the population, the phenotype measured, the design of the study, and environmental variation. Family resemblance can also capture shared circumstances. Adoption designs, within-family analyses, molecular genetics, and the accumulated consistency of findings strengthen confidence in inherited liability while leaving the specific biology of many cases incompletely explained.
Polygenic architecture and common variants
For the majority of cases, genetic susceptibility is polygenic: many common DNA variants contribute small individual increments to risk. A large genome-wide association meta-analysis included 38,691 people with ADHD and 186,843 comparison participants and identified 27 genome-wide significant risk loci. The findings implicated genes expressed during early brain development, alongside neuronal and cognitive domains. The statistical signals describe associations across large samples and do not identify a single ADHD gene or a diagnostic genetic signature. See Demontis and colleagues, Nature Genetics (2023).
Polygenic scores summarize portions of measured genetic liability across a set of markers. Their predictive accuracy is limited at the individual level, depends on ancestral representation and study methods, and is influenced by the outcome chosen. Such scores do not replace clinical assessment, and their limitations are especially important when results from one ancestry group are transferred to another.
Rare variants and neurodevelopmental overlap
Rare variants can carry larger individual effects, and research published in 2025 further implicates neuronal biology in genetic susceptibility to ADHD. The existence of rare high-impact variants broadens the genetic picture, particularly in people whose developmental histories include additional neurological or intellectual features. These findings do not imply that most ADHD is attributable to one rare mutation, nor do they justify routine genetic testing to confirm ordinary ADHD. Demontis and colleagues, Nature (2025) examine rare genetic contributors.
Genetic influences are partly shared with other neurodevelopmental and psychiatric conditions. Shared liability helps explain some patterns of co-occurrence, while diagnosis still depends on the distinct clinical criteria of each disorder. A family history of ADHD is valuable assessment information, but an absence of diagnosed relatives does not exclude ADHD; previous generations may never have been assessed.
Brain development and pathways linking risk to symptoms
Developing neural circuits
ADHD research implicates developing systems associated with attention, response regulation, motivation, executive control, and temporal processing. Molecular studies suggest that some risk signals act through processes important during brain development. Imaging and neuropsychological studies find group-level differences in aspects of brain structure, activation, and connectivity. These distributions overlap substantially between people with and without ADHD, and imaging cannot presently establish the cause of an individual's symptoms or serve as a stand-alone diagnostic test. The international consensus review summarizes the converging evidence and its limits.
A developmental framework recognizes multiple pathways to superficially similar symptoms. Problems sustaining effort can arise in contexts of insufficient reward, high cognitive demand, sleep disruption, stress, or difficulty regulating competing responses. Their relative importance can vary across tasks and development. Neurobiological models help generate hypotheses, but no single dopamine, frontal-lobe, or executive-function explanation exhausts the causal architecture of ADHD.
Dopamine, norepinephrine, and motivational regulation
Catecholamine signaling, including dopamine and norepinephrine, is important for attention regulation, working memory, behavioral selection, and reward-related learning. Pharmacological efficacy of medications acting on these pathways supports their relevance to symptom regulation. It cannot prove that all ADHD originates from a simple neurotransmitter deficiency. A treatment mechanism and an etiological cause are distinct concepts: a medication can modify a functional system without revealing why the disorder developed.
Temporal discounting, reward sensitivity, delay aversion, and effort allocation are active research domains. Some findings illuminate why a person may concentrate well on immediately rewarding tasks while struggling with low-feedback obligations. These patterns also occur outside ADHD and vary across individuals. Etiological accounts should therefore integrate cognitive and motivational models with inherited vulnerability, developmental history, and environmental demands.
Developmental timing and sensitive periods
Brain development begins prenatally and continues through childhood, adolescence, and adulthood. The consequences of a risk factor may depend on when exposure occurs, how long it lasts, the dose, and what other conditions coexist. Studies of prenatal influences must distinguish exposures during different trimesters; studies of childhood toxicants must distinguish current blood biomarkers from earlier cumulative exposures. Sensitive-period hypotheses are plausible, but specific causal windows are established for fewer proposed ADHD exposures than popular accounts suggest.
Prenatal influences: what pregnancy studies establish
Maternal smoking and the importance of family confounding
Population studies repeatedly associate smoking during pregnancy with later ADHD diagnoses or symptoms. A recent umbrella review synthesizing observational meta-analyses found an elevated association for maternal smoking, while also finding heterogeneity and evidence of familial confounding. Its paternal-smoking analysis was associated with elevated offspring ADHD risk as well, making simplistic intrauterine interpretations less persuasive. The umbrella review explicitly cautions that within-family research can attenuate associations.
A parent who smokes may also transmit inherited traits related to impulsivity or other vulnerabilities; parental ADHD may influence smoking behavior, stress exposure, and healthcare use. Sibling comparisons and paternal negative-control exposures help test whether prenatal exposure alone explains the association. These designs have their own limitations, but they illustrate why a strong observational link is not automatically a causal prenatal effect. Avoiding tobacco during pregnancy remains sound general obstetric and public-health advice because of its established harms, independent of uncertainty about the specific ADHD pathway.
Alcohol exposure and fetal alcohol spectrum disorders
Prenatal alcohol exposure can cause serious developmental harm, including the established fetal alcohol spectrum disorders (FASD). Attention deficits, impulsivity, executive challenges, and behavioral dysregulation may occur in affected children. Some children with FASD also meet ADHD criteria, while others have overlapping symptoms arising in a broader developmental phenotype. Clinicians should consider exposure history when relevant and assess possible FASD rather than treating attention symptoms as evidence of one unique cause.
The distinction matters epidemiologically. Evidence that alcohol can injure the developing nervous system does not imply that a specified proportion of ordinary ADHD diagnoses has been caused by alcohol. Reliable exposure measurement, co-occurring substance use, parental characteristics, and ascertainment of developmental disorders complicate population estimates. Clinical evaluation should address each condition on its own criteria and functional effects.
Cannabis and other psychoactive exposures
Studies of prenatal cannabis exposure and later attention or behavioral outcomes are subject to substantial confounding by nicotine and other substances, parental mental health, social adversity, and inherited characteristics. Definitions of exposure vary by potency, frequency, method of use, and pregnancy timing. Elevated symptom scores and registry-based ADHD outcomes cannot be treated interchangeably. Current evidence supports careful exposure assessment and pregnancy risk counseling, while the ADHD-specific causal magnitude remains uncertain.
For illicit or nonprescribed psychoactive substances, fetal risk evaluation involves the complete maternal and infant medical context. An etiological discussion should not attribute later ADHD to a reported isolated exposure without confirming its timing, dose, competing explanations, and the child's developmental phenotype.
Maternal medication exposure and the acetaminophen example
Medication safety in pregnancy requires particular attention to confounding by indication: fever, pain, infection, psychiatric symptoms, and other conditions can affect both medication use and child outcomes. A nationwide Swedish cohort of approximately 2.48 million children evaluated prenatal acetaminophen exposure and autism, ADHD, and intellectual disability. Ordinary population comparisons suggested small associations, but sibling-control analyses did not support the same interpretation as a causal medication effect. Ahlqvist and colleagues, JAMA (2024) illustrate why design choice changes conclusions.
This is a finding about one exposure and particular research designs, not a blanket guarantee for all medicines or situations. Pregnancy medication decisions should follow current clinical guidance about maternal indication, dose, alternative treatments, and benefits and risks. Stopping an indicated medicine without medical advice can create its own risks.
Maternal health, infection, inflammation, and metabolic conditions
Maternal hypertension, diabetes, obesity, infection, and psychosocial stress have been investigated as prenatal correlates of later ADHD. Some associations are reproducible across cohorts; however, their interpretation must account for genetic liability, parental age, medication use, access to care, and family socioeconomic circumstances. A World Federation of ADHD evidence synthesis reports associations for hypertensive pregnancy complications, while not granting all environmental correlates equivalent causal status.
Biologically plausible mechanisms include altered placental function, fetal growth restriction, inflammatory responses, and changes in nutrient or oxygen availability. Mechanistic plausibility is useful for designing studies, yet direct causal inference requires temporality, measurement quality, confounder control, replication, and ideally triangulation across multiple methods. Maternal health conditions warrant compassionate and appropriate care; risk statistics are not grounds for attributing responsibility to individual parents.
Prematurity, birth weight, and perinatal complications
Preterm birth and very low birth weight
Preterm birth is a relatively consistent developmental risk marker for later attentional and executive difficulties. The magnitude of association tends to be greater with more extreme prematurity and very low birth weight. The international ADHD consensus summarizes large studies and meta-analyses demonstrating elevated ADHD risk in these populations. Prematurity may reflect multiple interacting circumstances, including pregnancy complications, medical treatments, early sensory environments, and neurological vulnerability.
Prematurity does not imply that every child will develop ADHD. Many preterm children have typical outcomes, while others require developmental follow-up for attention, learning, motor, language, and emotional problems. Early support should be guided by observed needs rather than by an automatic prediction of an ADHD diagnosis.
Neonatal illness and complications of birth
Research also evaluates neonatal hypoxia, brain injury, neonatal intensive care exposures, and other medical events. Their associations with ADHD-like symptoms can be complicated by prematurity, gestational age, underlying congenital conditions, and common causes of medical intervention and later neurodevelopmental outcomes. Clinicians should consider neurological history when symptoms have an unusual course or broader pattern, while maintaining clear differentiation between ADHD, acquired injury, and other developmental disorders.
Birth-related risk markers are best interpreted as components of an integrated developmental history. A brief reported obstetric complication, without substantiating records and a plausible clinical course, cannot establish individual causation. Prospective medical records are generally more reliable than remote retrospective recollection for timing and severity.
Environmental toxicants and chemical exposure
Lead: a serious public-health exposure
Lead is a well-established neurotoxicant. Observational and meta-analytic research links childhood lead burden to increased ADHD diagnoses and to inattention and hyperactivity-impulsivity scores. A 2024 meta-analysis and a systematic review of chemical exposures support this association, while showing design and measurement limitations. These findings justify reducing children's lead exposure regardless of whether an individual child's ADHD can be attributed to it.
Exposure can arise from deteriorating lead paint, contaminated dust and soil, certain water systems and products, and occupationally transported residues. Public-health interventions focus on identifying sources, preventing further exposure, and following evidence-based medical evaluation. Lead testing addresses a possible toxic exposure; it is not an ADHD diagnostic test. An elevated blood lead level may warrant separate action even when formal ADHD criteria are absent.
Other heavy metals
Arsenic, manganese, mercury, and cadmium have been studied in relation to ADHD. A 2024 systematic review and meta-analysis identified a comparatively consistent signal for lead, while findings for several other metals depended on subgroup choices and sensitivity analyses; mercury and cadmium showed no significant overall association in that review. Differences in environmental measurements, exposure mixtures, sex, age, dietary intake, and regional conditions complicate inference.
A biomarker may indicate recent or cumulative exposure depending on the substance and specimen used. Comparisons of incompatible biomarkers can obscure both real effects and null findings. Environmental toxicology also examines neurodevelopmental outcomes wider than ADHD. It is scientifically inaccurate to infer that every neurotoxic exposure causes the specific syndrome ADHD.
Air pollution, pesticides, flame retardants, and endocrine-disrupting chemicals
Researchers investigate particulate air pollution, nitrogen oxides, pesticides, organophosphate metabolites, persistent organic pollutants, phthalates, bisphenols, and mixtures of these exposures. Some cohort studies report associations with later attention or behavioral ratings. Yet results differ with residential exposure estimation, timing, geography, co-exposure, socioeconomic gradients, outcome ascertainment, and statistical analysis. Strong general reasons to reduce avoidable air pollution and hazardous chemical exposure coexist with unresolved questions about the precise ADHD-specific causal contribution of many agents.
Chemical exposures rarely occur one at a time. Mixture models can better represent real environments, but highly correlated exposures make it difficult to identify which component matters. Studies should also consider reverse causation where a child's behavior influences the measured exposure context, as well as differential participation and diagnostic access.
Environmental prevention versus causal certainty
Prevention policy can act on credible toxic hazards without claiming that eliminating a particular pollutant will eliminate ADHD. Reducing lead exposure, improving air quality, preventing harmful workplace take-home contamination, and supporting safe housing have benefits across multiple health and developmental outcomes. Causal precision is especially important when translating population-level findings into counseling: reducing a risk factor can improve health while leaving most inherited and developmental sources of ADHD susceptibility intact.
Nutrition, food additives, and the microbiome
Nutrient status and overall diet
Iron, zinc, omega-3 fatty acids, vitamin D, and patterns of dietary intake have been examined in relation to ADHD symptoms. Observed nutritional differences can reflect numerous directions of influence: diet may affect cognition and behavior; ADHD-related impulsivity and routines may shape eating; medication may alter appetite; family circumstances can affect both. A nutrient association should not be recast as proof that deficiency caused the disorder, and a supplementation trial addresses intervention efficacy rather than all questions about original causation.
Good nutrition supports development and general health. A medical evaluation may identify specific deficiencies requiring treatment. Broad claims that particular foods, sugar, or a generic modern diet are the primary cause of ADHD extend beyond the available evidence. NICE clinical guidance supports balanced nutrition and does not recommend universal elimination diets as routine ADHD treatment.
Artificial food colors and elimination diets
Some controlled studies have investigated whether certain artificial colorings or mixtures of additives increase hyperactive behavior in some children. An effect on behavioral activity in a selected sample does not automatically imply causation of the neurodevelopmental disorder. Responses may differ by child, exposure, and design, and nutritional restriction has practical costs. The etiological question, the short-term symptom-modification question, and the treatment recommendation require different evidence standards.
When a family notices an apparent relationship between food and behavior, careful observation and appropriate pediatric or dietary consultation can help evaluate it. Broad restrictive regimens can carry nutritional risks. The existence of particular food sensitivities does not overturn the large body of genetic and developmental evidence.
Gut microbiome hypotheses
Microbiome research examines associations among intestinal microbial communities, immune signaling, metabolites, diet, medication, and brain function. Studies of ADHD remain heterogeneous in sample size, sequencing method, diet adjustment, antibiotic history, and treatment exposure. Distinctive bacterial profiles are not an established causal signature or validated clinical test for ADHD. Proposed gut-brain pathways are research hypotheses, and currently available microbiome-directed products do not have a demonstrated etiological corrective role.
Psychosocial environments: stress, adversity, and deprivation
Family adversity and chronic stress
Family conflict, economic insecurity, parental mental health difficulties, violence exposure, and childhood adversity may be associated with attention problems or an ADHD diagnosis. Such environments can also influence sleep, arousal, emotion regulation, educational opportunity, and access to clinical services. Genetic inheritance, parental ADHD traits, and social circumstances may be correlated with adversity, creating confounding that must be examined rather than presumed away.
Stress-related concentration difficulties can resemble ADHD symptoms, coexist with ADHD, or intensify existing impairment. Some children exposed to severe adversity have complex developmental, emotional, or trauma-related difficulties that demand independent assessment. A clinically thoughtful evaluation asks about timing, pervasiveness, onset, context, safety, and what happened before and after the exposure.
Severe early deprivation
Research on children exposed to profound early institutional deprivation supports the possibility that extreme deprivation can contribute to enduring attention and behavioral problems. Such cases illuminate developmental sensitivity to caregiving and environment, while their applicability to ordinary variations in parenting is limited. Generalizing from profound deprivation to the claim that typical parenting practices cause ADHD is not supported.
Parent-focused behavioral interventions can improve daily function and reduce conflict after ADHD is recognized. Their clinical value does not imply that poor parenting produced the original neurodevelopmental syndrome. Caregiver support is a treatment and participation resource, not a retrospective causal verdict.
Education, neighborhood conditions, and social determinants
Housing quality, neighborhood pollution, school resources, healthcare access, food security, exposure to violence, and availability of accommodations jointly shape how ADHD-related vulnerabilities are experienced and identified. Diagnostic prevalence may differ by systems of recognition, cultural expectations, referral patterns, and access to assessment. Social determinants can act through biological exposure, cumulative stress, or clinical ascertainment, and these pathways should be studied separately.
An educational setting with fragmented instructions and unpredictable routines can intensify impairment; a structured and responsive setting may make the same child's functioning substantially better. These effects demonstrate the importance of person-environment fit without requiring the classroom to have caused the underlying ADHD.
Screens, video games, and digital environments
Associations between intensive digital-media use and later attention difficulties attract public attention. Exposure may vary by content, timing, sleep displacement, family context, and the child's preexisting self-regulation. Children with ADHD symptoms may select especially rewarding media, creating reverse causation. Heavy media consumption can also reduce sleep or disrupt routines, worsening concentration independently of ADHD etiology.
Longitudinal associations do not establish that smartphones, short videos, or games are the primary cause of clinical ADHD. The correct question is whether a well-defined digital exposure precedes persistent clinically diagnosed ADHD after accounting for preexisting symptoms and confounding, and whether comparable findings hold in stronger designs. Practical limits around sleep and healthy routines can be reasonable without promoting unsupported single-cause explanations.
Traumatic brain injury and acquired attention problems
Injury to the developing brain can produce persistent attention, inhibition, and executive-function difficulties. Some people develop an ADHD-like syndrome following traumatic brain injury, and individuals with preexisting ADHD can also be at elevated injury risk through behavioral and situational pathways. These directions must be distinguished. Acquired attention deficits after an injury may require neurological and rehabilitation assessment in addition to consideration of ADHD diagnostic criteria.
A child who shows a sudden change after injury or illness needs evaluation of that event and its consequences. The prototypical developmental ADHD history usually involves symptoms beginning in childhood rather than a new syndrome appearing abruptly in adulthood. Sudden impairment should lead clinicians to investigate other causes including sleep disorders, medications, substance effects, mood disorders, and neurological conditions.
How scientists decide whether an environmental factor is causal
Prospective cohort studies
Prospective cohorts measure exposures before symptoms emerge, reducing some recall bias and establishing temporal order. However, temporality alone does not exclude confounding, missing data, measurement error, or differences in health-service contact. A registry diagnosis can depend on referral access, and parent or teacher ratings reflect the perspective and context of the observer. The best cohorts describe exposure timing, outcome ascertainment, confounders, and loss to follow-up.
Sibling comparisons and family-based designs
Sibling designs compare siblings who share many familial characteristics but differ in exposure. They can reduce confounding by factors shared within families, including portions of genetic liability and stable social context. They cannot remove all differences between pregnancies or guarantee accurate exposure measurement. If a conventional cohort association becomes much smaller in sibling comparisons, this raises serious questions about a direct causal interpretation. The large acetaminophen sibling study offers a clear illustration.
Negative controls and genetically informed methods
A negative-control exposure, such as a related exposure outside the biologically plausible window, can help identify shared confounding. Paternal-smoking comparisons are relevant to prenatal-smoking hypotheses, though paternal exposures may also have biological or environmental consequences. Twin studies, within-family genetic models, Mendelian randomization, adoption designs, and triangulation across different populations provide additional perspectives. None is immune to assumptions or bias, so agreement among methods is more compelling than a single sophisticated statistical technique.
Meta-analyses, umbrella reviews, and evidence grading
Meta-analysis increases statistical precision by combining studies, but pooled estimates can be misleading when the included studies share confounding or vary in measurement. An umbrella review of meta-analyses can reveal consistency, heterogeneity, small-study effects, and gaps in methodology. A convincing statistical association is a statement about the evidence for correlation; it is not automatically proof of an intervention-relevant causal effect. The 2025 smoking umbrella review is instructive because even strong overall associations require genetically informed interpretation.
Dose, timing, plausibility, replication, and alternative explanations
Investigators look for exposure gradients, biologically plausible pathways, correct chronological order, replicated results, and similar findings across distinct designs. Apparent dose-response patterns may reflect confounding; a plausible biological theory may have multiple equally plausible alternatives. Researchers also assess whether results withstand adjustment, subgroup analysis, missing-data assumptions, and alternative outcome definitions. Environmental science is strongest when uncertainty is specified rather than replaced by dramatic causal language.
Gene-environment interplay and developmental pathways
Genes and environments can be correlated. For example, inherited attentional and impulsivity traits may influence parental occupational exposures, smoking behavior, routines, stress levels, and children's exposure opportunities. A child may evoke different responses from teachers and caregivers because of emerging ADHD-related behavior. These processes complicate any attempt to partition development into independent inherited and environmental percentages.
Gene-environment interaction describes a different claim: the magnitude of a specific genetic association depends on a specific exposure, or an exposure effect varies by genetic background. Such interactions are difficult to estimate reliably and require large, well-measured samples. Many proposed ADHD interactions remain preliminary. A sophisticated developmental account can acknowledge both correlation and interaction while resisting the unsupported assumption that a particular exposure activates an identifiable ADHD gene.
Epigenetic research investigates molecular regulation of gene expression, including DNA methylation patterns associated with exposures and development. Epigenetic findings are often tissue-specific, sensitive to cell mixture and confounding, and observational in human studies. Claims that parental stress or a single lifestyle choice permanently switches ADHD on or off through epigenetics extend beyond established evidence.
Why ADHD differs across children, adolescents, and adults
Childhood onset and changing symptom visibility
ADHD is classified by a pattern of symptoms beginning in childhood. The same underlying liability can become visible earlier or later depending on demands and compensatory supports. Children may show overt restlessness and disruptive impulsivity, while adolescents struggle with planning, sleep schedules, homework, and sustained self-management. Different classroom structures and reporting practices alter the probability of referral, so age of diagnosis is not the same as age when a biological cause began.
Persistence, remission, and adult environments
ADHD symptoms and functional impairment can persist into adulthood, although their expression and intensity may change. Adult responsibilities involving independent scheduling, employment, parenting, and financial management can increase the functional consequences of executive difficulties. Such changes in environment explain variation in impairment without establishing a new adult-onset etiology. Adult assessment should seek credible childhood history and evaluate psychiatric, sleep, substance-related, and medical alternatives, following NICE.
Sex, gender, and unequal recognition
Differences in referral and diagnosis between boys and girls, and between men and women, can reflect symptom presentation, social expectations, ascertainment, and clinical bias as well as developmental biology. Girls and women with substantial inattention or internalized difficulties may be recognized later. Etiological claims based only on clinic samples should account for who was referred and who remained undiagnosed. Demographic differences in recorded prevalence are not by themselves direct evidence of distinct causal mechanisms.
Distinguishing causes from symptoms and related concepts
Inattention, hyperactivity, impulsivity, and executive dysfunction
Inattention, hyperactivity, and impulsivity are clinical symptom dimensions. Executive dysfunction describes difficulties involving cognitive control, planning, organization, flexible attention, working memory, and related processes. ADHD is the diagnostic condition in which developmentally inappropriate symptom patterns and impairment meet clinical criteria. Executive dysfunction can also occur with sleep disorders, depression, brain injuries, neurological conditions, and other neurodevelopmental disorders; it is not synonymous with ADHD or a uniquely demonstrated root cause.
A neuropsychological test can characterize aspects of cognition but is not an etiological test. Rating scales help organize information, while clinical diagnosis integrates functioning over time and settings. There is no established saliva test, blood biomarker, polygenic score, brain scan, or online questionnaire that independently verifies why an individual has ADHD. NICE recommendations explicitly require comprehensive assessment rather than ratings alone.
Hyperfocus, time blindness, masking, and rejection sensitivity
Hyperfocus and time blindness are widely used descriptions of intense engagement and difficulties with subjective time, planning, or prospective memory. ADHD masking refers to attempts to conceal or compensate for observable difficulties. Rejection sensitive dysphoria is a popular term for intense perceived rejection responses. These concepts can support discussion of lived experience, but they are not independent ADHD diagnoses or established etiological mechanisms. Their measurement and diagnostic specificity remain areas of inquiry, and experiences described by them can have multiple explanations.
Clinical questions should begin with observable behaviors, onset, impairment, and co-occurring conditions. Emotional reactivity or strong sensitivity to social feedback may deserve assessment, but its presence cannot establish the cause of ADHD. Descriptive language and causal explanation belong to different scientific levels.
Clinical implications: what a causes-of-ADHD history can and cannot do
A clinician may ask about family history, prematurity, developmental milestones, pregnancy complications, sleep, medical illness, neurological injury, possible toxic exposures, school history, and psychosocial adversity. These questions can reveal coexisting conditions, exposure-related health needs, or clues to differential diagnosis. They cannot usually identify a single causal source of ADHD. The absence of a recognized risk factor does not challenge an otherwise well-supported clinical diagnosis.
A child's chronic attention difficulty should be evaluated across home, school, and social settings; caregivers and teachers may provide complementary information. Relevant alternatives include sleep-disordered breathing, anxiety, depression, trauma-related difficulties, learning disorders, hearing or vision problems, medication effects, and other neurodevelopmental conditions. In adults, assessment additionally considers substance use, mood disorders, cognitive changes, and developmental history. Clinicians follow recognized diagnostic criteria and guidelines, rather than retrospectively inferring causation from popular symptom labels.
A suspected environmental toxic exposure deserves independent medical evaluation through appropriate local public-health and clinical services. Pregnancy and medication concerns should be discussed with qualified clinicians. Environmental modifications, evidence-based ADHD interventions, family support, and accessible education can reduce functional harm regardless of whether the original causal pathway is known.
Implications for prevention and public policy
Population prevention efforts should prioritize well-established health hazards and developmentally supportive environments. Lead abatement, prenatal care, substance-use prevention, occupational safeguards, safe housing, and follow-up for very preterm infants are valuable for reasons extending beyond ADHD. Researchers should evaluate whether targeted prevention reduces clinically assessed ADHD incidence rather than merely changing questionnaire scores or referral patterns.
Policies should avoid treating ADHD incidence as proof of a community's parenting quality or presumed individual behavior. Genetics, differential exposure, screening practices, healthcare access, and educational systems jointly influence recorded outcomes. The most credible public-health communication identifies actionable hazards, describes the certainty of ADHD-specific evidence, and preserves the clinical autonomy and dignity of people living with ADHD.
Research limitations and open scientific questions
Major gaps include ancestry diversity in genetic studies, sufficiently powered gene-environment interaction designs, reproducible measurement of chemical mixtures, long-term prospective exposure histories, and better separation of true incidence from diagnostic recognition. Studies sometimes aggregate symptom questionnaires with specialist diagnoses, reducing comparability. Prenatal studies may inadequately record parental ADHD, and retrospective childhood studies may suffer recall bias.
Neurobiological research also faces questions about developmental heterogeneity and the difference between group-level brain variation and individual clinical prediction. Reliable causal estimates for many candidate environmental risks remain under investigation. New genetic associations and molecular findings require functional validation before they can be interpreted as established cellular pathways. The growing ability to detect correlations should be matched by equally rigorous evaluation of what those correlations mean.
Frequently asked questions about ADHD causes
Is ADHD inherited from a parent?
ADHD has a substantial inherited component, and a diagnosed or undiagnosed family history may increase a person's likelihood of ADHD. Most cases involve many genetic variants, each contributing a small amount of risk. There is no simple inheritance rule, and a parent can have ADHD without every child developing it. Likewise, a child can have ADHD when no relative has received a diagnosis. Faraone and Larsson review the genetic evidence.
Can pregnancy complications cause ADHD?
Prematurity and several pregnancy complications are associated with elevated ADHD risk in large studies. The relationship can include biological effects, shared inherited liability, and characteristics of the pregnancies and families involved. Evidence for an association varies in its causal strength by exposure. Medical histories help assess developmental needs, but an obstetric event rarely establishes the unique cause of an individual's ADHD.
Does smoking during pregnancy cause ADHD?
Smoking during pregnancy has serious established health risks and is consistently associated with ADHD outcomes in observational datasets. However, sibling and familial research raises uncertainty about how much of the ADHD-specific association is caused directly by fetal tobacco exposure rather than shared genetic and family factors. A recent umbrella review documents both the association and the causal limitations.
Do vaccines cause ADHD?
Established ADHD etiological research does not identify routine childhood vaccination as a demonstrated cause of ADHD. Claims of causation require high-quality epidemiological evidence and plausible, reproducible mechanisms, not anecdotes about symptoms noticed after an event. Decisions about immunization should follow current professional public-health recommendations.
Can screens and gaming create ADHD?
Heavy digital-media use can affect sleep, routines, and attention, and children with existing ADHD traits may be drawn to high-reward digital activities. These intertwined pathways complicate causal conclusions. Current evidence does not support treating screen exposure as a single established origin of ADHD. Family media decisions can focus on sleep, balance, and observable functioning without attributing the disorder to a device.
Can bad parenting cause ADHD?
Ordinary parenting differences are not an established primary cause of ADHD. Family relationships and daily structure can affect behavior, stress, and impairment, and extreme developmental deprivation can contribute to attention problems through different pathways. Parent-focused interventions can be helpful because they improve support, not because a parent caused the underlying neurodevelopmental condition.
Is ADHD caused by low dopamine?
Dopamine is part of the neural systems involved in attention, reward, and behavioral regulation. A simple statement that an individual's ADHD was caused by low dopamine is not a validated etiological diagnosis. Drug responses and group-level neuroscience do not provide a direct test of the original cause in one person.
Can ADHD be prevented?
No intervention has been demonstrated to prevent every case of a multifactorial neurodevelopmental disorder. Avoiding lead and tobacco exposure, providing prenatal healthcare, addressing medical risks, and supporting child development are sound public-health measures. Their ADHD-specific preventive effects vary in evidentiary certainty. Early recognition and support can improve outcomes even when the disorder's original etiology remains unknown.
Related Articles
Cluster ADHD and Executive Function - The published scientific overview of ADHD development, executive function, assessment, and care.
ADHD and Sleep: Insomnia, Circadian Rhythms, and Daytime Symptoms - How sleep difficulties affect attention, daily functioning, and clinical assessment.
ADHD and Time Blindness: Time Perception, Estimation, and Evidence - Timing difficulties and the strength of their scientific evidence.
Does ADHD Go Away? Persistence and Change Across the Lifespan - Developmental persistence, change, and adulthood outcomes.
ADHD Treatment: Evidence-Based Options Across the Lifespan - The relationship between established diagnosis and intervention choices.
References
Ahlqvist, V. H., Sjöqvist, H., Dalman, C., et al. (2024). Acetaminophen use during pregnancy and children's risk of autism, ADHD, and intellectual disability. JAMA, 331, 1205-1214. https://doi.org/10.1001/jama.2024.3172
Centers for Disease Control and Prevention. (2024). ADHD in children: Symptoms and risk factors. https://www.cdc.gov/adhd/about/
Demontis, D., Duan, J., Hsu, Y.-H. H., et al. (2025). Rare genetic variants confer a high risk of ADHD and implicate neuronal biology. Nature. https://doi.org/10.1038/s41586-025-09702-8
Demontis, D., Walters, G. B., Athanasiadis, G., et al. (2023). Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains. Nature Genetics, 55, 198-208. https://doi.org/10.1038/s41588-022-01285-8
Dimitrov, L. V., Kaminski, J. W., Holbrook, J. R., et al. (2024). A systematic review and meta-analysis of chemical exposures and attention-deficit/hyperactivity disorder in children. Prevention Science, 25(Suppl 2), 225-248. https://doi.org/10.1007/s11121-023-01601-6
Faraone, S. V., Banaschewski, T., Coghill, D., et al. (2021). The World Federation of ADHD international consensus statement: 208 evidence-based conclusions about the disorder. Neuroscience and Biobehavioral Reviews, 128, 789-818. https://doi.org/10.1016/j.neubiorev.2021.01.022
Faraone, S. V., and Larsson, H. (2019). Genetics of attention deficit hyperactivity disorder. Molecular Psychiatry, 24, 562-575. https://doi.org/10.1038/s41380-018-0070-0
Gu, Q., Liu, J., Zhang, X., Huang, A., Yu, X., Wu, K., and Huang, Y. (2025). Association between heavy metals exposure and risk of attention deficit hyperactivity disorder (ADHD) in children: A systematic review and meta-analysis. European Child and Adolescent Psychiatry, 34, 921-941. https://doi.org/10.1007/s00787-024-02546-z
National Institute for Health and Care Excellence. (2018; updated guidance). Attention deficit hyperactivity disorder: Diagnosis and management (NG87). https://www.nice.org.uk/guidance/ng87/chapter/recommendations
National Institute of Mental Health. (n.d.). Attention-deficit/hyperactivity disorder: What you need to know. https://www.nimh.nih.gov/health/publications/attention-deficit-hyperactivity-disorder-what-you-need-to-know
Rosenauer, V., Schwarz, M. I., Vlasak, T., and Barth, A. (2024). Childhood lead exposure increases the risk of attention-deficit-hyperactivity disorder: A meta-analysis. Science of the Total Environment, 951, 175574. https://doi.org/10.1016/j.scitotenv.2024.175574
Tsegay, L., Zena, D., Abicho, A., Gizachew, Y., and Ayano, G. (2026). Maternal and paternal smoking during pregnancy and the risk of ADHD in offspring: An umbrella review of systematic reviews and meta-analyses. Journal of Psychiatric Research, 193, 441-446. https://doi.org/10.1016/j.jpsychires.2025.12.010